



Glimceed 2 PM Tablet (1*15)
Triple-combination anti-diabetic tablet containing Glimepiride, Pioglitazone, and Metformin for effective blood sugar control in Type 2 diabetes.
Glimceed 2 PM Tablet is a combination of Glimepiride (2 mg), Pioglitazone (15 mg), and Metformin Hydrochloride SR (500 mg) used in the management of Type 2 Diabetes Mellitus. This formulation works by:
Glimepiride: Stimulating the pancreas to produce more insulin.
Pioglitazone: Improving the body’s sensitivity to insulin.
Metformin: Reducing glucose production in the liver and increasing glucose uptake in muscles.
It is prescribed when diet, exercise, and single-drug therapy are insufficient to achieve adequate blood sugar control.
💊 Uses:
Type 2 Diabetes Mellitus
Improves insulin sensitivity
Reduces fasting and post-meal blood sugar
Prevents long-term diabetic complications
🌟 Benefits:
Triple-action formula for better glycemic control
Reduces both fasting and postprandial glucose
Supports long-term diabetes management
Convenient single-tablet combination
⚠️ Side Effects:
Hypoglycemia (low blood sugar)
Weight gain
Stomach discomfort
Swelling in ankles/feet
Rare: liver function changes
📌 How to Use:
Take with meals to reduce stomach upset
Swallow whole with water
Follow doctor’s dosage instructions
🛡️ Safety Advice:
Regularly monitor blood sugar levels
Avoid alcohol to reduce hypoglycemia risk
Not for patients with severe heart failure or liver disease
Consult a doctor before use in pregnancy or breastfeeding